Disposition kinetics of cobalt mesoporphyrin in mouse, rat, monkey and dog

Xenobiotica

Volumn 28, Issue 4, 1998, Pages 413-426

  Feng, M R ^a   Rossi, D T ^a   Strenkoski, C ^a   Black, A ^a   Dehart, P ^a   Lovdahl, M ^a   Mcnally, W ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT MESOPORPHYRIN; MESOPORPHYRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DOG; DRUG DISPOSITION; DRUG ELIMINATION; MONKEY; MOUSE; NONHUMAN; RADIOMETRY; RAT; TISSUE DISTRIBUTION; ULTRAVIOLET RADIATION; WHOLE BODY AUTORADIOGRAPHY;

EID: 0031977662     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982598239515     Document Type: Article

References (25)

1. ALTMAN, P. L. and DITTMER, D. S., 1974, Biology Data Book, 2nd edn, Vol III (Bethesda: Federation of American Societies for Experimental Biology).
2. ANDERSON, K., SIMIONATTO, C., DRUMMOND, G. and KAPPAS, A., 1984, Tissue distribution and disposition of tin-protoporphyrin, a potent competitive inhibitor of heme oxygenase. Journal of Pharmacology and Experimental, 228, 327-333.
3. ANDERSON, K., SIMIONATTO, C., DRUMMOND, G. and KAPPAS, A., 1986, Disposition of tinprotoporphyrin and suppression of hyperbilirubinemia in human. Clinical Pharmacology and Therapeutics 39, 510-520.
4. BERNAREGGI, A. and ROWLAND, M., 1991, Physiologic meeting of cyclosporin kinetics in rat and man. Journal of Pharmacokinetics and Biopharmacology, 1, 21-50.
5. CANNON, J. B., 1993, Pharmaceutics and drug delivery aspects to heme and porphyrin therapy. Journal of Pharmaceutical Science, 83, 435-446.
6. DAVIES, B. and NORRIS, T., 1993, Physiological parameters in laboratory animals and humans. Pharmacology Research, 7, 1093-1095.
7. DEDRICK, R. L. and FORRESTER, D. D., 1973, Blood flow limitation in interpreting michaelis constants for ethanol oxidation in vivo. Biochemical Pharmacology 22, 1133-1140.
8. GALBRAITH, R. A. and KAPPAS, A., 1989a, Pharmacokinetics of tin-mesoporphyrin in man and the effects of tin-chelated porphyrins on hyperexcretion of heme pathway precursors in patients with acute inducible porphyria. Hepatology, 6, 882-888.
9. GALBRAITH, R. A. and KAPPAS, A., 1989b, Regulation of food intake and body weight by cobalt porphyrins in animals. Proceedings of the National Academy of Sciences, USA, 10, 7653-7657.
10. GALBRAITH, R. A. and KAPPAS, A., 1989c, Regulation of food intake and body weight by cobalt porphyrins in animals. Proceedings of the National Academy of Sciences, USA, 86, 7653-7657.
11. GALBRAITH, R. A. and KAPPAS, A., 1990, Cobalt protoporphyrin suppresses expression of genetic obesity in homozygous (fa/fa) Zucker rats. Pharmacology, 41, 292-298.
12. GALBRAITH, R. A. and KAPPAS, A., 1991a, Intracerebroventricular administration of cobalt protoporphyrin elicits prolonged weight reduction in rats. American Journal of Physiology, 261, R1395-1401.
13. GALBRAITH, R. A. and KAPPAS, A., 1991b, Regulation of food intake and body weight in rats by synthetic heme analogue cobalt porphyrin. American Journal of Physiology, 261, R1388-1394.
14. GALBRAITH, R. A. and KAPPAS, A., 1991c, Cobalt protoporphyrin regulates body weight in beagle dogs: incubation of weight loss in normal animals of stable adult weight. Pharmacology, 43, 96-105.
15. GALBRAITH, R. A., KOW, L., PFAFF, D. and KAPPAS, A., 1992a, Injection of cobalt protoporphyrin into the medical nuclei of the hypothalamus elicits weight loss. American Journal of Physiology, 262, R805-812.
16. GALBRATTH, R. A., CHUA JR S. and KAPPAS, A., 1992b, Hypothalamic mechanism for cobalt protoporphyrin-induced hypophagia and weight loss: inhibition of feeding response to NPY. Molecular Brain Research, 15, 298-302.
17. HOFFMAN, K., ROSSI, D., FENG, M. R., WRIGHT, D. S. and CHANG, T., 1996, Pharmacokinetic profiling of cobalt mesoporphyrin in rat plasma using atomic absorption spectroscopy. Poster presented at the 1996 Parke-Davis Analytical Symposium in Holland, MI, USA.
18. MORDENTI, J., 1986, Man versus beast: pharmacokinetic scaling in mammals. Journal of Pharmacological Science, 11, 1028-1040.
19. OHNHAUS, E. E. and LOCHER, J. T., 1975, Liver blood flow and blood volume following chronic phenobarbitone administration, European Journal of Pharmacology, 31, 161-165.
20. ROSENBERG, D., 1993, Pharmacokinetics of cobalt chloride and cobalt-protoporphyrin. Drug Metabolism and Disposition, 21, 846-849.
21. RUSSO, S., PEPE, J., DONOHUE, S., CABLE, E., LAMBRECHT, R. and BONKOVSKY, H., 1995, Tissue distribution of zinc-mesoporphyrin in rats: relationship to inhibition of heme oxygenase. Journal of Pharmacology and Experimental Therapeutics, 272, 766-774.
22. ULLBERG, S., 1954, Studies on the distribution and fate of 35S-labelled benzylpenicillin in the body. Acta Radiologica, suppl. 118, 1-110.
23. WILEY, J. N., JOHNSON, S. J. and HEFFNER, T., 1977, Effect of cobalt mesoporphyrin on feeding and weight gain in rats and dogs. Poster presented at the 1997 Neuroscience Annual Meeting, New Orleans, LA, USA.
24. YANNI, S., CHISM, J., RICKERT, D. and SERABJIT-SINGH, C., 1993, Diminished drug metabolism due to hormonal effects of cobalt mesoporphyrin on flavoproteins. Chemico-Biological Interactions, 89, 73-87.
25. YATES, M. S., HILEG, C. R., ROBERTS, P. J., BACK, D. J. and CRAWFORD, F. E., 1973, Differential effects of hepatic microsomal enzyme inducing agents on liver blood flow. Biochemical Pharmacology, 62, 882-890.